Clinical Trial Update: Candesartan for Migraine Prevention: [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating candesartan for migraine prevention has completed. The study was sponsored by St. Olavs Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Candesartan (candesartan)

Snippet

Sponsor: St. Olavs Hospital | Conditions: Migraine | Phase 2 | Status: COMPLETED